These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36539128)

  • 41. Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.
    Zou J; Chen Z; Liang C; Fu Y; Wei X; Lu J; Pan M; Guo Y; Liao X; Xie H; Wu D; Li M; Liang L; Wang P; Wang Q
    Aging Dis; 2018 Feb; 9(1):51-65. PubMed ID: 29392081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
    Bhattacharjee N; Mazumder MK; Paul R; Choudhury A; Choudhury S; Borah A
    Neurosci Lett; 2016 Aug; 628():225-9. PubMed ID: 27283777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma Homocysteine in Patients with Coronary and Carotid Artery Disease: A Case Control Study.
    Bosevski M; Zlatanovikj N; Petkoska D; Gjorgievski A; Lazarova E; Stojanovska L
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2020 Jun; 41(1):15-22. PubMed ID: 32573476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship among Serum Homocysteine, Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Visual Impairment in Diabetic Macular Edema.
    Fu J; Zhu J
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):57-60. PubMed ID: 34983149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a relationship between homocysteine and vitiligo? A pilot study.
    Shaker OG; El-Tahlawi SM
    Br J Dermatol; 2008 Sep; 159(3):720-4. PubMed ID: 18616781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Some aspects of homocysteine metabolism in hemodialysis patients].
    Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
    Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The Influence of Serum Homocysteine Level to the Prognosis of Newly Diagnosed Multiple Myeloma Patients and Analysis of Related Factors].
    Fu Y; Wei XF; Feng YF; Liu F; Chen QL; Zhao YY; Zhang WJ; Ma T; Huang XJ; Chen Y; Li QF; Zhang QK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):530-534. PubMed ID: 33812426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levels and clinical significance of serum homocysteine (Hcy), high-density lipoprotein cholesterol (HDL-C), vaspin, and visfatin in elderly patients with different types of coronary heart disease.
    Guan J; Wu L; Xiao Q; Pan L
    Ann Palliat Med; 2021 May; 10(5):5679-5686. PubMed ID: 34107717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid.
    Ozdemir O; Yakut A; Dinleyici EC; Aydogdu SD; Yarar C; Colak O
    Eur J Pediatr; 2011 Jul; 170(7):873-7. PubMed ID: 21140275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease.
    Bhattacharjee N; Borah A
    Neurochem Int; 2016 Dec; 101():48-55. PubMed ID: 27732886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.
    Bakeberg MC; Jefferson A; Riley M; Byrnes M; Ghosh S; Mastaglia FL; Horne MK; McGregor S; Stell R; Kenna J; Walters S; Hince D; Anderton RS
    Parkinsons Dis; 2019; 2019():3124295. PubMed ID: 31275543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of entacapone on plasma homocysteine in Parkinson's disease patients on levodopa].
    Zhao P; Yang JF; Liu W; Wang Y; Sun YN; Li Q; Zhang W; Zhang BS
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):512-5. PubMed ID: 23660319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated Serum Matrix Metalloproteinase-9, Interleukin-6, Hypersensitive C-Reactive Protein, and Homocysteine Levels in Patients with Epilepsy.
    Tao H; Gong Y; Yu Q; Zhou H; Liu Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):152-158. PubMed ID: 31971845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral Neuropathy in
    Lee JJ; Baik JS
    Yonsei Med J; 2020 Dec; 61(12):1050-1053. PubMed ID: 33251779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
    Lee SH; Kim MJ; Kim BJ; Kim SR; Chun S; Kim HK; Ryu JS; Kim GS; Lee MC; Chung SJ; Koh JM
    Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical course in Parkinson's disease with elevated homocysteine.
    O'Suilleabhain PE; Oberle R; Bartis C; Dewey RB; Bottiglieri T; Diaz-Arrastia R
    Parkinsonism Relat Disord; 2006 Mar; 12(2):103-7. PubMed ID: 16368256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Correlation between Serum Homocysteine Level, MTHFR Gene Polymorphism and Patients with Hematological Diseases Complicated with Coronary Heart Disease].
    Zhang L; Yuan XF; Li Q; Fan L; Chen Z; Zhang B; Gao BH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):305-309. PubMed ID: 35123644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients.
    Nevrly M; Kanovsky P; Vranova H; Langova K; Hlustik P
    Neurol Sci; 2010 Oct; 31(5):565-9. PubMed ID: 20464572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment.
    Rozycka A; Jagodzinski PP; Kozubski W; Lianeri M; Dorszewska J
    Curr Genomics; 2013 Dec; 14(8):534-42. PubMed ID: 24532985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.